🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Natàlia Llopart

Max Planck Institute for Molecular Biomedicine

ORCID: 0000-0002-3127-2901

Also affiliated with Universitat de Barcelona

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’””.

Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”

Molecular Psychiatry(2024)10.1038/s41380-024-02864-3
N/A
0.104DataRank · unranked
1 citations

Paulo Alexandre de Oliveira, Nil Casajuana-Martín, César Quiroz, Reece C. Budinich, Rana Rais +15 more

Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c01763
N/A
0DataRank · unranked
24 citations

Verònica Casadó-Anguera, Marc Gómez‐Autet, Natàlia Llopart, Estefanía Moreno, Nil Casajuana-Martín +5 more

Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

Molecular Psychiatry(2023)10.1038/s41380-023-02353-z
N/A
0DataRank · unranked
27 citations

Paulo Alexandre de Oliveira, Nil Casajuana-Martín, César Quiroz, Reece C. Budinich, Rana Rais +15 more